New combo therapy aims to slow advanced breast cancer in BRCA patients
NCT ID NCT06201234
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding elacestrant to the standard drug olaparib can help people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has a BRCA gene mutation. About 176 participants will be randomly assigned to receive either the combination or olaparib alone. The goal is to see if the combination delays cancer growth and improves quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Agaplesion Frankfurter Diakonie Kliniken gGmbH
RECRUITINGFrankfurt am Main, Hesse, 60431, Germany
-
Caritas Traegergesellschaft Saarbruecken mbH (CTS)
RECRUITINGSaarbrücken, Saarland, 66113, Germany
-
Das Brust Zentrum - Die Frauenärzte
RECRUITINGBerlin, State of Berlin, 12623, Germany
-
GRN Klinik Weinheim
RECRUITINGWeinheim, Baden-Württembergs, 69469, Germany
-
Gemeinschaftspraxis Dr.Illmer, Dr. Wolf, Dr. Jacobasch, Dr. Freiberg-Richter
RECRUITINGDresden, Saxony, Germany
-
Heinrich-Heine-Universität Düsseldorf
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
-
Helios Universitätsklinikum Wuppertal
RECRUITINGWuppertal, North Rhine-Westphalia, 42283, Germany
-
Hämatologie-Onkologie im Zentrum MVZ GmbH
RECRUITINGAugsburg, Bavaria, 86150, Germany
-
Institut für Versorgungsforschung Mayen
RECRUITINGMayen, Rhineland-Palatinate, Germany
-
KEM Kliniken Essen-Mitte GmbH
RECRUITINGEssen, North Rhine-Westphalia, 45136, Germany
-
Klinikum Bayreuth
RECRUITINGBayreuth, Bavaria, Germany
-
Klinikum Kassel GmbH - Frauenklinik
RECRUITINGKassel, Hesse, 34125, Germany
-
Klinikum Worms
RECRUITINGWorms, 67550, Germany
-
Klinikum der J. W. Goethe Universität
RECRUITINGFrankfurt am Main, Hesse, 60590, Germany
-
MVZ Onkologische Kooperation Harz GbR
RECRUITINGGoslar, Lower Saxony, Germany
-
Marienhospital Bottrop gGmbH
RECRUITINGBottrop, 46236, Germany
-
Marienhospital Witten
RECRUITINGWitten, North Rhine-Westphalia, 58452, Germany
-
MediOnko-Institut GbR
RECRUITINGBerlin, State of Berlin, 10367, Germany
-
Medizinische Hochschule Hannover
RECRUITINGHanover, Lower Saxony, Germany
-
National Center for Tumor Diseases Heidelberg
RECRUITINGHeidelberg, 69120, Germany
-
Rems-Murr-Klinik-Winnenden
RECRUITINGWinnenden, Baden-Wurttemberg, Germany
-
Robert Bosch Gesellschaft fuer medizinische Forschung mbH
RECRUITINGStuttgart, Germany
-
Rotkreuzklinikum München
RECRUITINGMünchen, 80634, Germany
-
Schwerpunktpraxis der Gynäkologie und Onkologie
RECRUITINGFürstenwalde, Brandenburg, 15517, Germany
-
St. Josefs-Hospital, Gynäkologie und Geburtshilfe
RECRUITINGWiesbaden, Hesse, 65189, Germany
-
Studien GbR Braunschweig
RECRUITINGBraunschweig, Lower Saxony, 38100, Germany
-
Studienzentrum Onkologie Ravensburg
RECRUITINGRavensburg, 88212, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
-
University Hospital Carl Gustav Carus
RECRUITINGDresden, Saxony, 01307, Germany
-
University Hospital Tübingen
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
Universität Leipzig
RECRUITINGLeipzig, Saxony, Germany
-
Universitätsklinik Köln
NOT_YET_RECRUITINGCologne, North Rhine-Westphalia, Germany
-
Universitätsklinikum Essen - Klinik für Frauenheilkunde und Geburtshilfe
RECRUITINGEssen, 45147, Germany
-
Universitätsklinikum des Saarlandes - Frauenklinik
RECRUITINGHomburg, 66424, Germany
-
Vinzenz Von Paul Kliniken gGmbH - Marienhospital
RECRUITINGStuttgart, Baden-Wurttemberg, Germany
-
Zentrum für Gynäkologische Onkologie am MVZ Medical Center Düsseldorf GmbH
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40235, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging tracer could spot hidden cancers
- Could a 'Baby Dose' of hormone pills prevent breast cancer?
- Toolkit aims to break the silence around inherited cancer genes
- New hope for tough breast cancer: targeted drug HLX43 enters phase 2 trial
- Ibrance under the microscope: Real-World data on advanced breast cancer treatment
- Can online therapy calm BRCA1/2 women's fear of cancer return?